BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35353393)

  • 21. A new classification of lymph node metastases according to the lymph node stations for predicting prognosis in surgical patients with esophageal squamous cell carcinoma.
    Lin Z; Chen W; Chen Y; Peng X; Zhu K; Lin Y; Lin Q; Hu Z
    Oncotarget; 2016 Nov; 7(46):76261-76273. PubMed ID: 27788489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Towards developing a meaningful grading system for cervical squamous cell carcinoma.
    McCluggage WG
    J Pathol Clin Res; 2018 Apr; 4(2):81-85. PubMed ID: 29665326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of zinc finger E-box binding homeobox factor 1 promotes tumor invasiveness and confers unfavorable prognosis in esophageal squamous cell carcinoma.
    Yang X; Wang Q; Dai W; Zhang J; Chen X
    Tumour Biol; 2014 Dec; 35(12):11977-84. PubMed ID: 25142232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
    Li W; Liu J; Zhao H
    Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
    Wang WT; Guo CQ; Cui GH; Zhao S
    World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.
    Guan S; Wang C; Chen X; Liu B; Tan B; Liu F; Wang D; Han L; Wang L; Huang X; Wang J; Yao B; Shi J; Chen P; Nesa EU; Song Q; Cheng Y
    Tumour Biol; 2016 Apr; 37(4):4383-91. PubMed ID: 26499784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma.
    Ning ZH; Zhao W; Li XD; Chen LJ; Xu B; Gu WD; Shao YJ; Xu Y; Huang J; Pei HL; Jiang JT
    Int J Clin Exp Pathol; 2015; 8(6):6881-90. PubMed ID: 26261575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of tumour-associated macrophages with cancer cell EMT, invasion, and metastasis of Kazakh oesophageal squamous cell cancer.
    Liu J; Li C; Zhang L; Liu K; Jiang X; Wang X; Yang L; Liang W; Liu K; Hu J; Li F
    Diagn Pathol; 2019 Jun; 14(1):55. PubMed ID: 31186031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgrouping.
    Jesinghaus M; Steiger K; Slotta-Huspenina J; Drecoll E; Pfarr N; Meyer P; Konukiewitz B; Bettstetter M; Wieczorek K; Ott K; Feith M; Langer R; Weichert W; Specht K; Boxberg M
    Oncotarget; 2017 Jul; 8(29):46756-46768. PubMed ID: 28657901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of visual residual tumour cells (VRTC) for patients with esophageal squamous cell carcinomas after neoadjuvant therapy followed by surgery.
    Wang X; Wang H; Wang H; Huang J; Wang X; Jiang Z; Tan L; Jiang D; Hou Y
    BMC Cancer; 2021 Feb; 21(1):111. PubMed ID: 33535987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upregulation of long noncoding RNA LEF1-AS1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma.
    Zong MZ; Feng WT; Du N; Yu XJ; Yu WY
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7929-7934. PubMed ID: 31599448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel pathological predictive factors for extranodal extension in oral squamous cell carcinoma: a retrospective cohort study based on tumor budding, desmoplastic reaction, tumor-infiltrating lymphocytes, and depth of invasion.
    Noda Y; Ishida M; Ueno Y; Fujisawa T; Iwai H; Tsuta K
    BMC Cancer; 2022 Apr; 22(1):402. PubMed ID: 35418058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poor prognostic impact of FGF4 amplification in patients with esophageal squamous cell carcinoma.
    Huang J; Song Q; Wang H; Wang H; Xu C; Wang X; Jiang Z; Wang Y; Xu Y; Su J; Zeng H; Tan L; Zhu H; Jiang D; Hou Y
    Hum Pathol; 2018 Oct; 80():210-218. PubMed ID: 29936056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Novel Prognostic Stratified System Based on Tumor Budding and the Cell Nest Size in Ureter Urothelial Carcinoma.
    Li J; Li X; Yang J
    Appl Bionics Biomech; 2022; 2022():6988237. PubMed ID: 35572056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of tumor regression grade for patients with esophageal squamous cell carcinoma after neoadjuvant chemotherapy followed by surgery.
    Hatogai K; Fujii S; Kojima T; Daiko H; Kadota T; Fujita T; Yoshino T; Doi T; Takiguchi Y; Ohtsu A
    J Surg Oncol; 2016 Mar; 113(4):390-6. PubMed ID: 27100024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-155 acts as a diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma.
    Zheng YJ; Liang TS; Wang J; Zhao JY; Zhai SN; Yang DK; Wang LD
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):977-982. PubMed ID: 32573268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prognostic value and molecular properties of tertiary lymphoid structures in oesophageal squamous cell carcinoma.
    Ling Y; Zhong J; Weng Z; Lin G; Liu C; Pan C; Yang H; Wei X; Xie X; Wei X; Zhang H; Wang G; Fu J; Wen J
    Clin Transl Med; 2022 Oct; 12(10):e1074. PubMed ID: 36245289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beclin-1 is a Promising Prognostic Biomarker in a Specific Esophageal Squamous Cell Carcinoma Population.
    Du H; Luo F; Shi M; Che J; Zhu L; Li H; Hang J
    Pathol Oncol Res; 2021; 27():594724. PubMed ID: 34257544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of preoperative lymphocyte-monocyte ratio in patients with resectable esophageal squamous cell carcinoma.
    Han LH; Jia YB; Song QX; Wang JB; Wang NN; Cheng YF
    Asian Pac J Cancer Prev; 2015; 16(6):2245-50. PubMed ID: 25824745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic values of apoptosis-stimulating P53-binding protein 1 and 2 and their relationships with clinical characteristics of esophageal squamous cell carcinoma patients: a retrospective study.
    Xie XF; Yang Q; Chi J; Yang XZ; Wang HY; Xu GL
    Chin J Cancer; 2017 Jan; 36(1):15. PubMed ID: 28103919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.